EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Keberadaan Jentik Aedes sp. pada Controllable Sites dan Dispossable Sites di Indonesia (Studi Kasus di 15 Provinsi)

Revi Rosavika Kinansi, Triwibowo Ambar Garjito, Mega Tyas Prihatin, Muhammad Choirul Hidajat, Yusnita Mirna Anggraeni, Wening Widjajanti

ASPIRATOR - Journal of Vector-borne Disease Studies · 2019

DOI: 10.22435/asp.v11i1.540 ↗
AbstractBibliografische Angaben

Abstract

Dengue Hemorrhagic Fever is still a major public health problem in Indonesia. Increased dengue cases in Indonesia cannot be separated from the presence of Aedes sp. as an infectious vector. One of the factors that influence the incidence of Dengue Haemorrhagic Fever (DHF) is the number of Aedes sp. larvae. The larva population is strongly influenced by the characteristics of its habitat. Data of Riset Khusus Vektora 2016 contains the level of larvae density of Aedes sp. through a water reservoir seen from controllable sites and dispossable sites. Data was taken in 15 provinces in Indonesia, Aceh, West Sumatra, Lampung, Bangka Belitung, West Java, East Java, Banten, West Nusa Tenggara, East Nusa Tenggara, West Kalimantan, South Kalimantan, North Sulawesi, Southeast Sulawesi, Maluku, and North Maluku. The results obtained in this study were examined from 11,491 container, obtained 11,301 controllable sites and 190 dispossable sites. Larvae were found more on controllable sites because it is used in everyday life. There are 18 districts/cities that have a medium density figure category and 27 districts/cities are categorized as having high larvae densities. The way that is considered effective and appropriate in preventing and eradicating DHF is by eradicating its transmitting mosquito nest (PSN-DBD) through the 3M plus movement which requires the participation of all levels of society.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →